메뉴 건너뛰기




Volumn 24, Issue 3, 2013, Pages 358-369

Memantine and cholinesterase inhibitors: Complementary mechanisms in the treatment of Alzheimer's disease

Author keywords

Acetylcholine; Alzheimer's disease; Cholinesterase inhibitors; Glutamate; Mechanism of action; Memantine

Indexed keywords

ACETYLCHOLINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO; RIVASTIGMINE;

EID: 84883459353     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-013-9398-z     Document Type: Review
Times cited : (256)

References (111)
  • 1
    • 0026609559 scopus 로고
    • Alternative excitotoxic hypotheses
    • 1314341 1:STN:280:DyaK383ivVWmuw%3D%3D
    • Albin RL, Greenamyre JT (1992) Alternative excitotoxic hypotheses. Neurology 42:733-738
    • (1992) Neurology , vol.42 , pp. 733-738
    • Albin, R.L.1    Greenamyre, J.T.2
  • 2
    • 84872664970 scopus 로고    scopus 로고
    • Memantine reverses β-amyloid oligomers-induced deficits in long-term potentiation (LTP) in murine hippocampal slices
    • Nov 15-18, Washington, USA
    • Albrecht M, Rammes G, Gravius A, Parsons CG (2008) Memantine reverses β-amyloid oligomers-induced deficits in long-term potentiation (LTP) in murine hippocampal slices. Poster presented at 38th Society for Neuroscience Annual Meeting, Nov 15-18, Washington, USA
    • (2008) 38th Society for Neuroscience Annual Meeting
    • Albrecht, M.1    Rammes, G.2    Gravius, A.3    Parsons, C.G.4
  • 3
    • 32544439510 scopus 로고    scopus 로고
    • Simultaneous release of glutamate and acetylcholine from single magnocellular "cholinergic" basal forebrain neurons
    • 16452682 1:CAS:528:DC%2BD28XhsFaitLc%3D
    • Allen TG, Abogadie FC, Brown DA (2006) Simultaneous release of glutamate and acetylcholine from single magnocellular "cholinergic" basal forebrain neurons. J Neurosci 26:1588-1595
    • (2006) J Neurosci , vol.26 , pp. 1588-1595
    • Allen, T.G.1    Abogadie, F.C.2    Brown, D.A.3
  • 5
    • 52649127458 scopus 로고    scopus 로고
    • Long-term course and effectiveness of combination therapy in Alzheimer disease
    • 18580597 1:CAS:528:DC%2BD1cXhtVOiu7%2FE
    • Atri A, Shaughnessy LW, Locascio JJ, Growdon JH (2008) Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord 22:209-221
    • (2008) Alzheimer Dis Assoc Disord , vol.22 , pp. 209-221
    • Atri, A.1    Shaughnessy, L.W.2    Locascio, J.J.3    Growdon, J.H.4
  • 6
    • 84872399089 scopus 로고    scopus 로고
    • Memantine in patients with Alzheimer's disease receiving donepezil: New analyses of efficacy and safety for combination therapy
    • 23336974 1:CAS:528:DC%2BC3sXjs12msbk%3D
    • Atri A, Molinuevo JL, Lemming O, Wirth Y, Pulte I, Wilkinson D (2013) Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy. Alzheimers Res Ther 5:6
    • (2013) Alzheimers Res Ther , vol.5 , pp. 6
    • Atri, A.1    Molinuevo, J.L.2    Lemming, O.3    Wirth, Y.4    Pulte, I.5    Wilkinson, D.6
  • 7
    • 0036810329 scopus 로고    scopus 로고
    • Alzheimer's disease and the basal forebrain cholinergic system: Relations to beta-amyloid peptides, cognition, and treatment strategies
    • 12450488 1:CAS:528:DC%2BD38XovFeiurk%3D
    • Auld DS, Kornecook TJ, Bastianetto S, Quirion R (2002) Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68:209-245
    • (2002) Prog Neurobiol , vol.68 , pp. 209-245
    • Auld, D.S.1    Kornecook, T.J.2    Bastianetto, S.3    Quirion, R.4
  • 8
    • 0034718202 scopus 로고    scopus 로고
    • Chronic treatment of old rats with donepezil or galantamine: Effects on memory, hippocampal plasticity and nicotinic receptors
    • 10924948 1:CAS:528:DC%2BD3cXlt1Kis74%3D
    • Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL (2000) Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 99:17-23
    • (2000) Neuroscience , vol.99 , pp. 17-23
    • Barnes, C.A.1    Meltzer, J.2    Houston, F.3    Orr, G.4    McGann, K.5    Wenk, G.L.6
  • 9
    • 77953625660 scopus 로고    scopus 로고
    • Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease
    • 20540654 1:CAS:528:DC%2BC3cXnsVWgtbo%3D
    • Bassil N, Thaipisuttikul P, Grossberg GT (2010) Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease. Expert Opin Pharmacother 11:1765-1771
    • (2010) Expert Opin Pharmacother , vol.11 , pp. 1765-1771
    • Bassil, N.1    Thaipisuttikul, P.2    Grossberg, G.T.3
  • 10
    • 0020453289 scopus 로고
    • Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: A combined fluorescent tracer and acetylcholinesterase analysis
    • 6182962 1:CAS:528:DyaL38XlvFelsbY%3D
    • Bigl V, Woolf NJ, Butcher LL (1982) Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis. Brain Res Bull 8:727-749
    • (1982) Brain Res Bull , vol.8 , pp. 727-749
    • Bigl, V.1    Woolf, N.J.2    Butcher, L.L.3
  • 11
    • 44949179484 scopus 로고    scopus 로고
    • Cholinesterase inhibitors for Alzheimer's disease
    • doi: 10.1002/14651858
    • Birks J (2009) Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 1:CD005593. doi: 10.1002/14651858
    • (2009) Cochrane Database Syst Rev , vol.1
    • Birks, J.1
  • 12
    • 0032950029 scopus 로고    scopus 로고
    • The glutamatergic system and neurodegeneration in dementia: Preventive strategies in Alzheimer's disease
    • 10029935 1:STN:280:DyaK1M7lsVWqtQ%3D%3D
    • Cacabelos R, Takeda M, Winblad B (1999) The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease. Int J Geriatr Psychiatry 14:3-47
    • (1999) Int J Geriatr Psychiatry , vol.14 , pp. 3-47
    • Cacabelos, R.1    Takeda, M.2    Winblad, B.3
  • 13
    • 34447625351 scopus 로고    scopus 로고
    • ®) in clinical practice - Results of an observational study
    • 17622714 1:CAS:528:DC%2BD2sXotVajs7o%3D
    • ®) in clinical practice - results of an observational study. Dement Geriatr Cogn Disord 24:111-117
    • (2007) Dement Geriatr Cogn Disord , vol.24 , pp. 111-117
    • Calabrese, P.1    Essner, U.2    Förstl, H.3
  • 14
    • 0025642962 scopus 로고
    • Sources of presumptive glutamatergic/aspartatergic afferents to the magnocellular basal forebrain in the rat
    • 1982006 1:STN:280:DyaK3M7osFKluw%3D%3D
    • Carnes KM, Fuller TA, Price JL (1990) Sources of presumptive glutamatergic/aspartatergic afferents to the magnocellular basal forebrain in the rat. J Comp Neurol 302:824-852
    • (1990) J Comp Neurol , vol.302 , pp. 824-852
    • Carnes, K.M.1    Fuller, T.A.2    Price, J.L.3
  • 15
    • 0026564448 scopus 로고
    • Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity
    • 1432103 1:CAS:528:DyaK3sXntlY%3D
    • Chen H-SV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA (1992) Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12:4427-4436
    • (1992) J Neurosci , vol.12 , pp. 4427-4436
    • Chen, H.-S.1    Pellegrini, J.W.2    Aggarwal, S.K.3    Lei, S.Z.4    Warach, S.5    Jensen, F.E.6    Lipton, S.A.7
  • 16
    • 33746825134 scopus 로고    scopus 로고
    • Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment
    • Memantine MEM-MD-02 Study Group 16832078 1:CAS:528:DC%2BD28XlvFylu7o%3D
    • Cummings JL, Schneider E, Tariot PN, Graham SM, Memantine MEM-MD-02 Study Group (2006) Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology 67:57-63
    • (2006) Neurology , vol.67 , pp. 57-63
    • Cummings, J.L.1    Schneider, E.2    Tariot, P.N.3    Graham, S.M.4
  • 17
    • 33644835280 scopus 로고    scopus 로고
    • Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment
    • 16409439 1:CAS:528:DC%2BD28XitFSltbs%3D
    • Dantoine T, Auriacombe S, Sarazin M, Becker H, Pere JJ, Bourdeix I (2006) Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment. Int J Clin Pract 60:110-118
    • (2006) Int J Clin Pract , vol.60 , pp. 110-118
    • Dantoine, T.1    Auriacombe, S.2    Sarazin, M.3    Becker, H.4    Pere, J.J.5    Bourdeix, I.6
  • 18
    • 0141707078 scopus 로고    scopus 로고
    • The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: Preclinical evidence
    • 12973747
    • Danysz W, Parsons CG (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int J Geriatr Psychiatry 18:S23-S32
    • (2003) Int J Geriatr Psychiatry , vol.18
    • Danysz, W.1    Parsons, C.G.2
  • 19
    • 0001788650 scopus 로고    scopus 로고
    • Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease - A unified glutamatergic hypothesis on the mechanism of action
    • 16787834 1:CAS:528:DC%2BD3cXot1Cqsrg%3D
    • Danysz W, Parsons CG, Mobius HJ, Stoffler A, Quack G (2000) Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease - a unified glutamatergic hypothesis on the mechanism of action. Neurotox Res 2:85-97
    • (2000) Neurotox Res , vol.2 , pp. 85-97
    • Danysz, W.1    Parsons, C.G.2    Mobius, H.J.3    Stoffler, A.4    Quack, G.5
  • 20
    • 0035896466 scopus 로고    scopus 로고
    • Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease
    • 11226635 1:CAS:528:DC%2BD3MXhsFSiurc%3D
    • Davidsson P, Blennow K, Andreasen N, Eriksson B, Minthon L, Hesse C (2001) Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease. Neurosci Lett 300:157-160
    • (2001) Neurosci Lett , vol.300 , pp. 157-160
    • Davidsson, P.1    Blennow, K.2    Andreasen, N.3    Eriksson, B.4    Minthon, L.5    Hesse, C.6
  • 21
    • 34249672242 scopus 로고    scopus 로고
    • Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine
    • 17308309
    • De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590-11601
    • (2007) J Biol Chem , vol.282 , pp. 11590-11601
    • De Felice, F.G.1    Velasco, P.T.2    Lambert, M.P.3    Viola, K.4    Fernandez, S.J.5    Ferreira, S.T.6    Klein, W.L.7
  • 22
    • 1842453883 scopus 로고    scopus 로고
    • Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones
    • 14744806
    • Di Angelantonio S, Bernardi G, Mercuri NB (2004) Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones. Br J Pharmacol 141:644-652
    • (2004) Br J Pharmacol , vol.141 , pp. 644-652
    • Di Angelantonio, S.1    Bernardi, G.2    Mercuri, N.B.3
  • 23
    • 0028826399 scopus 로고
    • Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: Implications for Alzheimer's disease
    • 7595503 1:CAS:528:DyaK2MXovFGmtb4%3D
    • Dijk SN, Francis PT, Stratmann GC, Bowen DM (1995) Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: implications for Alzheimer's disease. J Neurochem 65:2165-2169
    • (1995) J Neurochem , vol.65 , pp. 2165-2169
    • Dijk, S.N.1    Francis, P.T.2    Stratmann, G.C.3    Bowen, D.M.4
  • 25
    • 0017652462 scopus 로고
    • Memory and cognitive function in man: Does the cholinergic system have a specific role?
    • 560649 1:STN:280:DyaE2s3jtlSisw%3D%3D
    • Drachman DA (1977) Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 27:783-790
    • (1977) Neurology , vol.27 , pp. 783-790
    • Drachman, D.A.1
  • 26
    • 79955744677 scopus 로고    scopus 로고
    • The cholinergic system and hippocampal plasticity
    • 21130117 1:CAS:528:DC%2BC3MXmtFClu7o%3D
    • Drever BD, Riedel G, Platt B (2011) The cholinergic system and hippocampal plasticity. Behav Brain Res 221:505-514
    • (2011) Behav Brain Res , vol.221 , pp. 505-514
    • Drever, B.D.1    Riedel, G.2    Platt, B.3
  • 27
    • 3242690679 scopus 로고    scopus 로고
    • Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain
    • 15275830 1:CAS:528:DC%2BD2cXmtVCjtbk%3D
    • Enz A, Gentsch C (2004) Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain. Neuropharmacology 47:408-413
    • (2004) Neuropharmacology , vol.47 , pp. 408-413
    • Enz, A.1    Gentsch, C.2
  • 28
    • 0035283713 scopus 로고    scopus 로고
    • Basal forebrain glutamatergic modulation of cortical acetylcholine release
    • 11169769 1:CAS:528:DC%2BD3MXns1GhsQ%3D%3D
    • Fadel J, Sarter M, Bruno JP (2001) Basal forebrain glutamatergic modulation of cortical acetylcholine release. Synapse 39:201-212
    • (2001) Synapse , vol.39 , pp. 201-212
    • Fadel, J.1    Sarter, M.2    Bruno, J.P.3
  • 29
    • 0035964226 scopus 로고    scopus 로고
    • A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
    • Donepezil MSAD Study Investigators Group 11524468 1:CAS:528: DC%2BD3MXmslymtrg%3D
    • Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E, Donepezil MSAD Study Investigators Group (2001) A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology 57:613-620
    • (2001) Neurology , vol.57 , pp. 613-620
    • Feldman, H.1    Gauthier, S.2    Hecker, J.3    Vellas, B.4    Subbiah, P.5    Whalen, E.6
  • 30
    • 33845439410 scopus 로고    scopus 로고
    • Activities of daily living in moderate-to-severe Alzheimer disease: An analysis of the treatment effects of memantine in patients receiving stable donepezil treatment
    • Memantine MEM-MD-02 Study Group 17132971 1:CAS:528:DC%2BD28Xht1Cnt77N
    • Feldman HH, Schmitt FA, Olin JT, Memantine MEM-MD-02 Study Group (2006) Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment. Alzheimer Dis Assoc Disord 20:263-268
    • (2006) Alzheimer Dis Assoc Disord , vol.20 , pp. 263-268
    • Feldman, H.H.1    Schmitt, F.A.2    Olin, J.T.3
  • 31
    • 0346729783 scopus 로고    scopus 로고
    • Cortical acetylcholine release and electroencephalogram activation evoked by ionotropic glutamate receptor agonists in the rat basal forebrain
    • 14706791 1:CAS:528:DC%2BD2cXosFWr
    • Fournier GN, Materi LM, Semba K, Rasmusson DD (2004) Cortical acetylcholine release and electroencephalogram activation evoked by ionotropic glutamate receptor agonists in the rat basal forebrain. Neuroscience 123:785-792
    • (2004) Neuroscience , vol.123 , pp. 785-792
    • Fournier, G.N.1    Materi, L.M.2    Semba, K.3    Rasmusson, D.D.4
  • 33
    • 0027269660 scopus 로고
    • Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: Investigative and therapeutic perspectives
    • 8473885 1:CAS:528:DyaK3sXktVKjsrY%3D
    • Francis PT, Sims NR, Procter AW, Bowen DM (1993) Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives. J Neurochem 60:1589-1604
    • (1993) J Neurochem , vol.60 , pp. 1589-1604
    • Francis, P.T.1    Sims, N.R.2    Procter, A.W.3    Bowen, D.M.4
  • 35
    • 19144372322 scopus 로고    scopus 로고
    • Effects of memantine on behavioural symptoms in Alzheimer's disease patients: An analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies
    • 15852444 1:STN:280:DC%2BD2M3ivVKrug%3D%3D
    • Gauthier S, Wirth Y, Möbius HJ (2005) Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int J Geriatr Psychiatry 20:459-464
    • (2005) Int J Geriatr Psychiatry , vol.20 , pp. 459-464
    • Gauthier, S.1    Wirth, Y.2    Möbius, H.J.3
  • 36
    • 0141818332 scopus 로고    scopus 로고
    • Cholinergic function and Alzheimer's disease
    • 12973744
    • Giacobini E (2003) Cholinergic function and Alzheimer's disease. Int J Geriatr Psychiatry 18:S1-S5
    • (2003) Int J Geriatr Psychiatry , vol.18
    • Giacobini, E.1
  • 37
    • 0024810785 scopus 로고
    • The cholinergic receptor system of the human brain: Neurochemical and pharmacological aspects in aging and Alzheimer
    • 2685904 1:CAS:528:DyaK3cXktVertrw%3D
    • Giacobini E, DeSarno P, Clark B, McIlhany M (1989) The cholinergic receptor system of the human brain: neurochemical and pharmacological aspects in aging and Alzheimer. Prog Brain Res 79:335-343
    • (1989) Prog Brain Res , vol.79 , pp. 335-343
    • Giacobini, E.1    Desarno, P.2    Clark, B.3    McIlhany, M.4
  • 39
    • 0028218273 scopus 로고
    • NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus - A microdialysis study
    • 8120631 1:CAS:528:DyaK2cXitV2hsbg%3D
    • Giovannini MG, Mutolo D, Bianchi L, Michelassi A, Pepeu G (1994) NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus - a microdialysis study. J Neurosci 14:1358-1365
    • (1994) J Neurosci , vol.14 , pp. 1358-1365
    • Giovannini, M.G.1    Mutolo, D.2    Bianchi, L.3    Michelassi, A.4    Pepeu, G.5
  • 40
    • 0024363934 scopus 로고
    • Excitatory amino acids and Alzheimer's disease
    • 2554168 1:CAS:528:DyaL1MXmtFalsLY%3D
    • Greenamyre JT, Young AB (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol Aging 10:593-602
    • (1989) Neurobiol Aging , vol.10 , pp. 593-602
    • Greenamyre, J.T.1    Young, A.B.2
  • 41
    • 80051795817 scopus 로고    scopus 로고
    • A multinational, randomized, double-blind, placebo-controlled parallel-group trial of memantine extended-release capsule (28 mg, once daily) in patients with moderate to severe Alzheimer's disease
    • Grossberg GT, Manes F, Allegri R (2008) A multinational, randomized, double-blind, placebo-controlled parallel-group trial of memantine extended-release capsule (28 mg, once daily) in patients with moderate to severe Alzheimer's disease. Alzheimers Dement 4:T793
    • (2008) Alzheimers Dement , vol.4 , pp. 793
    • Grossberg, G.T.1    Manes, F.2    Allegri, R.3
  • 42
    • 18044388911 scopus 로고    scopus 로고
    • Memantine does not influence AChE inhibition in rat brain by donepezil or rivastigmine but does with DFP and metrifonate in in vivo studies
    • 1:CAS:528:DC%2BD2MXktFSrurg%3D
    • Gupta RC, Dekundy A (2005) Memantine does not influence AChE inhibition in rat brain by donepezil or rivastigmine but does with DFP and metrifonate in in vivo studies. Drug Dev Res 64:71-81
    • (2005) Drug Dev Res , vol.64 , pp. 71-81
    • Gupta, R.C.1    Dekundy, A.2
  • 44
    • 0037345885 scopus 로고    scopus 로고
    • Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy
    • 12598818
    • Hartmann S, Möbius HJ (2003) Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy. Int Clin Psychopharmacol 18:81-85
    • (2003) Int Clin Psychopharmacol , vol.18 , pp. 81-85
    • Hartmann, S.1    Möbius, H.J.2
  • 47
    • 0027491609 scopus 로고
    • Changes in G protein-mediated signal transduction in aging and Alzheimer's disease
    • 8239310 1:CAS:528:DyaK2cXnsVegtA%3D%3D
    • Joseph JA, Cutler R, Roth GS (1993) Changes in G protein-mediated signal transduction in aging and Alzheimer's disease. Ann N Y Acad Sci 695:42-45
    • (1993) Ann N y Acad Sci , vol.695 , pp. 42-45
    • Joseph, J.A.1    Cutler, R.2    Roth, G.S.3
  • 48
    • 0026706896 scopus 로고
    • Memantine prevents quinolinic acid-induced hippocampal damage
    • 1425971 1:CAS:528:DyaK38XmtVGjtbY%3D
    • Keilhoff G, Wolf G (1992) Memantine prevents quinolinic acid-induced hippocampal damage. Eur J Pharmacol 219:451-454
    • (1992) Eur J Pharmacol , vol.219 , pp. 451-454
    • Keilhoff, G.1    Wolf, G.2
  • 49
    • 53749087290 scopus 로고    scopus 로고
    • Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine
    • 18690555 1:CAS:528:DC%2BD1cXhtVSgtLrL
    • Kenney JW, Gould TJ (2008) Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 38:101-121
    • (2008) Mol Neurobiol , vol.38 , pp. 101-121
    • Kenney, J.W.1    Gould, T.J.2
  • 50
    • 34248509900 scopus 로고    scopus 로고
    • Molecules that disrupt memory circuits in Alzheimer's disease: The attack on synapses by Aβ oligomers (ADDLs)
    • B. Bontempi A.J. Silva Y. Christen (eds) Springer Berlin
    • Klein WL, Lacor PN, De Felice FG, Ferreira ST (2007) Molecules that disrupt memory circuits in Alzheimer's disease: the attack on synapses by Aβ oligomers (ADDLs). In: Bontempi B, Silva AJ, Christen Y (eds) Memories: molecules and circuits. Springer, Berlin, pp 155-179
    • (2007) Memories: Molecules and Circuits , pp. 155-179
    • Klein, W.L.1    Lacor, P.N.2    De Felice, F.G.3    Ferreira, S.T.4
  • 52
    • 0031048111 scopus 로고    scopus 로고
    • Psychotogenicity and N-methyl-d-aspartate receptor antagonism: Implications for neuroprotective pharmacotherapy
    • 9018383 1:CAS:528:DyaK2sXotlaqtA%3D%3D
    • Kornhuber J, Weller M (1997) Psychotogenicity and N-methyl-d-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biol Psychiatry 41:135-144
    • (1997) Biol Psychiatry , vol.41 , pp. 135-144
    • Kornhuber, J.1    Weller, M.2
  • 53
    • 80054896238 scopus 로고    scopus 로고
    • Economic evaluation of the impact of memantine on time to nursing home admission in the treatment of Alzheimer disease
    • 22014692
    • Lachaine J, Beauchemin C, Legault M, Bineau S (2011) Economic evaluation of the impact of memantine on time to nursing home admission in the treatment of Alzheimer disease. Can J Psychiatry 56:596-604
    • (2011) Can J Psychiatry , vol.56 , pp. 596-604
    • Lachaine, J.1    Beauchemin, C.2    Legault, M.3    Bineau, S.4
  • 54
    • 33846633336 scopus 로고    scopus 로고
    • Aβ oligomers-induced aberrations in synapse composition, shape and density provide a molecular basis for loss of connectivity in Alzheimer's disease
    • 17251419 1:CAS:528:DC%2BD2sXhs1Wrsbc%3D
    • Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Aβ oligomers-induced aberrations in synapse composition, shape and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807
    • (2007) J Neurosci , vol.27 , pp. 796-807
    • Lacor, P.N.1    Buniel, M.C.2    Furlow, P.W.3    Clemente, A.S.4    Velasco, P.T.5    Wood, M.6    Viola, K.L.7    Klein, W.L.8
  • 55
    • 0031765270 scopus 로고    scopus 로고
    • Glutamate toxicity in chronic neurodegenerative disease
    • 9932386 1:CAS:528:DyaK1cXotVCmurc%3D
    • Lancelot E, Beal MF (1998) Glutamate toxicity in chronic neurodegenerative disease. Prog Brain Res 116:331-347
    • (1998) Prog Brain Res , vol.116 , pp. 331-347
    • Lancelot, E.1    Beal, M.F.2
  • 57
    • 84876918518 scopus 로고    scopus 로고
    • Combination of memantine and donepezil reverses cognitive deficits in transgenic mice with both amyloid-beta plaques and neurofibrillary tangles
    • Sept 12-16, Istanbul, Turkey
    • Martinez-Coria H, Green K, Banerjee PK, LaFerla FM (2009) Combination of memantine and donepezil reverses cognitive deficits in transgenic mice with both amyloid-beta plaques and neurofibrillary tangles. Poster presented at 22nd Congress of the European College of Neuropsychopharmacology (ECNP), Sept 12-16, Istanbul, Turkey
    • (2009) 22nd Congress of the European College of Neuropsychopharmacology (ECNP)
    • Martinez-Coria, H.1    Green, K.2    Banerjee, P.K.3    Laferla, F.M.4
  • 60
    • 0021319490 scopus 로고
    • Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey
    • 6538106
    • Mesulam MM, Mufson EJ (1984) Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey. Brain 107:253-274
    • (1984) Brain , vol.107 , pp. 253-274
    • Mesulam, M.M.1    Mufson, E.J.2
  • 61
    • 0018385416 scopus 로고
    • The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory
    • 450929 1:CAS:528:DyaE1MXktFeqtL8%3D
    • Mewaldt SP, Ghoneim MM (1979) The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory. Pharmacol Biochem Behav 10:205-210
    • (1979) Pharmacol Biochem Behav , vol.10 , pp. 205-210
    • Mewaldt, S.P.1    Ghoneim, M.M.2
  • 62
    • 0037146905 scopus 로고    scopus 로고
    • Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1-40)
    • 12468047 1:CAS:528:DC%2BD38XptFelurg%3D
    • Miguel-Hidalgo JJ, Alvarex XA, Cacabelos R, Quack G (2002) Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1-40). Brain Res 958:210-221
    • (2002) Brain Res , vol.958 , pp. 210-221
    • Miguel-Hidalgo, J.J.1    Alvarex, X.A.2    Cacabelos, R.3    Quack, G.4
  • 63
    • 0030052030 scopus 로고    scopus 로고
    • Learning deficits induced by chronic intraventricular infusion of quinolinic acid - Protection by MK-801 and memantine
    • 8720470 1:CAS:528:DyaK28XkslKqtw%3D%3D
    • Misztal M, Frankiewicz T, Parsons CG, Danysz W (1996) Learning deficits induced by chronic intraventricular infusion of quinolinic acid - protection by MK-801 and memantine. Eur J Pharmacol 296:1-8
    • (1996) Eur J Pharmacol , vol.296 , pp. 1-8
    • Misztal, M.1    Frankiewicz, T.2    Parsons, C.G.3    Danysz, W.4
  • 64
    • 0029931273 scopus 로고    scopus 로고
    • Septal and hippocampal glutamate receptors modulate the output of acetylcholine in hippocampus: A microdialysis study
    • 8667007 1:CAS:528:DyaK28Xjs1yjt78%3D
    • Moor E, Auth F, DeBoer P, Westerink BHC (1996) Septal and hippocampal glutamate receptors modulate the output of acetylcholine in hippocampus: a microdialysis study. J Neurochem 67:310-316
    • (1996) J Neurochem , vol.67 , pp. 310-316
    • Moor, E.1    Auth, F.2    Deboer, P.3    Westerink, B.H.C.4
  • 65
    • 0036125305 scopus 로고    scopus 로고
    • Glutamate exacerbates amyloid beta1-42-induced impairment of long-term potentiation in rat hippocampal slices
    • 11928725 1:CAS:528:DC%2BD38XhslyjsLc%3D
    • Nakagami Y, Oda T (2002) Glutamate exacerbates amyloid beta1-42-induced impairment of long-term potentiation in rat hippocampal slices. Jpn J Pharmacol 88:223-226
    • (2002) Jpn J Pharmacol , vol.88 , pp. 223-226
    • Nakagami, Y.1    Oda, T.2
  • 66
    • 84861523642 scopus 로고    scopus 로고
    • Synergistic effects of antidementia drugs on spatial learning and recall in the APP23 transgenic mouse model of Alzheimer's disease
    • 22414570 1:CAS:528:DC%2BC38Xnt1Cis74%3D
    • Neumeister KL, Riepe MW (2012) Synergistic effects of antidementia drugs on spatial learning and recall in the APP23 transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 30:245-251
    • (2012) J Alzheimers Dis , vol.30 , pp. 245-251
    • Neumeister, K.L.1    Riepe, M.W.2
  • 67
    • 0033006151 scopus 로고    scopus 로고
    • Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide
    • 10426500 1:CAS:528:DyaK1MXksVegsbw%3D
    • Noda M, Nakanishi H, Akaike N (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92:1465-1474
    • (1999) Neuroscience , vol.92 , pp. 1465-1474
    • Noda, M.1    Nakanishi, H.2    Akaike, N.3
  • 68
    • 0035251677 scopus 로고    scopus 로고
    • Nicotinic receptor abnormalities of Alzheimer's disease: Therapeutic implications
    • 11230871 1:CAS:528:DC%2BD3MXhsFSjtbw%3D
    • Nordberg A (2001) Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 49:200-210
    • (2001) Biol Psychiatry , vol.49 , pp. 200-210
    • Nordberg, A.1
  • 69
    • 79955746908 scopus 로고    scopus 로고
    • The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine
    • 20553766 1:CAS:528:DC%2BC3MXmtFCksr0%3D
    • Nyakas C, Granic I, Halmy LG, Banerjee P, Luiten PG (2011) The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine. Behav Brain Res 221:594-603
    • (2011) Behav Brain Res , vol.221 , pp. 594-603
    • Nyakas, C.1    Granic, I.2    Halmy, L.G.3    Banerjee, P.4    Luiten, P.G.5
  • 70
    • 0025282045 scopus 로고
    • Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
    • 2165009 1:CAS:528:DyaK3cXltFeju7k%3D
    • Palmer AM, Gershon S (1990) Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? FASEB J 4:2745-2752
    • (1990) FASEB J , vol.4 , pp. 2745-2752
    • Palmer, A.M.1    Gershon, S.2
  • 71
    • 0027731677 scopus 로고
    • Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5- dimethyladamantan)
    • 8152525 1:CAS:528:DyaK2cXpsFGrtA%3D%3D
    • Parsons CG, Gruner R, Rozental J, Millar J, Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32:1337-1350
    • (1993) Neuropharmacology , vol.32 , pp. 1337-1350
    • Parsons, C.G.1    Gruner, R.2    Rozental, J.3    Millar, J.4    Lodge, D.5
  • 72
    • 0032467053 scopus 로고    scopus 로고
    • Glutamate in CNS disorders as a target for drug development: An update
    • 15616669 1:CAS:528:DyaK1MXhs12lsr8%3D
    • Parsons CG, Danysz W, Quack G (1998) Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect 11:523-569
    • (1998) Drug News Perspect , vol.11 , pp. 523-569
    • Parsons, C.G.1    Danysz, W.2    Quack, G.3
  • 73
    • 0032968779 scopus 로고    scopus 로고
    • Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: In vitro and in vivo characterization
    • 10193901 1:CAS:528:DyaK1MXhsF2htr0%3D
    • Parsons CG, Danysz W, Bartmann A, Spielmanns P, Frankiewicz T, Hesselink M, Eilbacher B, Quack G (1999a) Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization. Neuropharmacology 38:85-108
    • (1999) Neuropharmacology , vol.38 , pp. 85-108
    • Parsons, C.G.1    Danysz, W.2    Bartmann, A.3    Spielmanns, P.4    Frankiewicz, T.5    Hesselink, M.6    Eilbacher, B.7    Quack, G.8
  • 74
    • 0032892343 scopus 로고    scopus 로고
    • Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist - A review of preclinical data
    • 10465680 1:CAS:528:DyaK1MXjslGjsbY%3D
    • Parsons CG, Danysz W, Quack G (1999b) Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 38:735-767
    • (1999) Neuropharmacology , vol.38 , pp. 735-767
    • Parsons, C.G.1    Danysz, W.2    Quack, G.3
  • 75
    • 34948842904 scopus 로고    scopus 로고
    • Memantine: A NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - Too little activation is bad, too much is even worse
    • 17904591 1:CAS:528:DC%2BD2sXhtFGrsLzF
    • Parsons CG, Stöffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse. Neuropharmacology 53:699-723
    • (2007) Neuropharmacology , vol.53 , pp. 699-723
    • Parsons, C.G.1    Stöffler, A.2    Danysz, W.3
  • 76
    • 79959987552 scopus 로고    scopus 로고
    • Combination therapy for Alzheimer's disease
    • 21721598 1:CAS:528:DC%2BC3MXhtFGgu7zO
    • Patel L, Grossberg GT (2011) Combination therapy for Alzheimer's disease. Drugs Aging 28:539-546
    • (2011) Drugs Aging , vol.28 , pp. 539-546
    • Patel, L.1    Grossberg, G.T.2
  • 77
    • 4143051189 scopus 로고    scopus 로고
    • Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil
    • 15266045 1:CAS:528:DC%2BD2cXnslyisbg%3D
    • Periclou AP, Ventura D, Sherman T, Rao N, Abramowitz WT (2004) Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil. Ann Pharmacother 38:1389-1394
    • (2004) Ann Pharmacother , vol.38 , pp. 1389-1394
    • Periclou, A.P.1    Ventura, D.2    Sherman, T.3    Rao, N.4    Abramowitz, W.T.5
  • 78
    • 0018078940 scopus 로고
    • Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
    • 719462 1:STN:280:DyaE1M%2Fmtlarsw%3D%3D
    • Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2:1457-1459
    • (1978) Br Med J , vol.2 , pp. 1457-1459
    • Perry, E.K.1    Tomlinson, B.E.2    Blessed, G.3    Bergmann, K.4    Gibson, P.H.5    Perry, R.H.6
  • 79
    • 0033018477 scopus 로고    scopus 로고
    • Acetylcholine in mind: A neurotransmitter correlate of consciousness?
    • 10354606 1:CAS:528:DyaK1MXjvVemtbY%3D
    • Perry E, Walker M, Grace J, Perry R (1999) Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 22:273-280
    • (1999) Trends Neurosci , vol.22 , pp. 273-280
    • Perry, E.1    Walker, M.2    Grace, J.3    Perry, R.4
  • 80
    • 0017755565 scopus 로고
    • Scopolamine induced learning failures in man
    • 406632 1:CAS:528:DyaE2sXkslymtLo%3D
    • Petersen RC (1977) Scopolamine induced learning failures in man. Psychopharmacology 52:283-289
    • (1977) Psychopharmacology , vol.52 , pp. 283-289
    • Petersen, R.C.1
  • 81
    • 33845922830 scopus 로고    scopus 로고
    • The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: Clinical implications for treatment of Alzheimer's disease
    • 17192682 1:CAS:528:DC%2BD28XhtlWgurnN
    • Popa RV, Pereira EF, Lopes C, Maelicke A, Albuquerque EX (2006) The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease. J Mol Neurosci 30:227-232
    • (2006) J Mol Neurosci , vol.30 , pp. 227-232
    • Popa, R.V.1    Pereira, E.F.2    Lopes, C.3    Maelicke, A.4    Albuquerque, E.X.5
  • 82
    • 42149142899 scopus 로고    scopus 로고
    • Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial
    • Memantine MEM-MD-12 Study Group 18288936 1:CAS:528:DC%2BD1cXitF2kurs%3D
    • Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT, Memantine MEM-MD-12 Study Group (2008) Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Curr Alzheimer Res 5:83-89
    • (2008) Curr Alzheimer Res , vol.5 , pp. 83-89
    • Porsteinsson, A.P.1    Grossberg, G.T.2    Mintzer, J.3    Olin, J.T.4
  • 83
    • 0037417238 scopus 로고    scopus 로고
    • Memantine in moderate-to-severe Alzheimer's disease
    • Memantine Study Group 12672860 1:CAS:528:DC%2BD3sXis1egt7k%3D
    • Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Mobius HJ, Memantine Study Group (2003) Memantine in moderate-to-severe Alzheimer's disease. New Engl J Med 348:1333-1341
    • (2003) New Engl J Med , vol.348 , pp. 1333-1341
    • Reisberg, B.1    Doody, R.2    Stöffler, A.3    Schmitt, F.4    Ferris, S.5    Mobius, H.J.6
  • 84
    • 84883447525 scopus 로고    scopus 로고
    • Combination of Memantine and cholinesterase inhibitors in the treatment of AD
    • Schmidtke K, Holthoff V, Kressig RW, Molinuevo JL (2011) Combination of Memantine and cholinesterase inhibitors in the treatment of AD. Neurology News 1:1-8
    • (2011) Neurology News , vol.1 , pp. 1-8
    • Schmidtke, K.1    Holthoff, V.2    Kressig, R.W.3    Molinuevo, J.L.4
  • 85
    • 33845452780 scopus 로고    scopus 로고
    • Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: An exploratory reanalysis
    • for the Memantine MEM-MD-02 Study Group 17132970 1:CAS:528: DC%2BD28Xht1Cnt77M
    • Schmitt FA, van Dyck CH, Wichems CH, Olin JT, for the Memantine MEM-MD-02 Study Group (2006) Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis. Alzheimer Dis Assoc Disord 20:255-262
    • (2006) Alzheimer Dis Assoc Disord , vol.20 , pp. 255-262
    • Schmitt, F.A.1    Van Dyck, C.H.2    Wichems, C.H.3    Olin, J.T.4
  • 86
    • 43649099862 scopus 로고    scopus 로고
    • Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: An open-label, crossover, single-centre study
    • 18479178 1:CAS:528:DC%2BD1cXosFGks74%3D
    • Shua-Haim J, Smith J, Picard F, Sedek G, Athalye S, Pommier F, Lefevre G (2008) Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: an open-label, crossover, single-centre study. Clin Drug Investig 28:361-374
    • (2008) Clin Drug Investig , vol.28 , pp. 361-374
    • Shua-Haim, J.1    Smith, J.2    Picard, F.3    Sedek, G.4    Athalye, S.5    Pommier, F.6    Lefevre, G.7
  • 88
    • 27744527103 scopus 로고    scopus 로고
    • Divergent effects of Abeta1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo
    • 16248989 1:CAS:528:DC%2BD2MXht1ensr%2FK
    • Szegedi V, Juhász G, Budai D, Penke B (2005) Divergent effects of Abeta1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo. Brain Res 1062:120-126
    • (2005) Brain Res , vol.1062 , pp. 120-126
    • Szegedi, V.1    Juhász, G.2    Budai, D.3    Penke, B.4
  • 89
    • 78650057569 scopus 로고    scopus 로고
    • Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors
    • 20947502 1:CAS:528:DC%2BC3cXhsFChtL3E
    • Takata K, Kitamura Y, Saeki M et al (2010) Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. J Biol Chem 285:40180-40191
    • (2010) J Biol Chem , vol.285 , pp. 40180-40191
    • Takata, K.1    Kitamura, Y.2    Saeki, M.3
  • 90
    • 0345872128 scopus 로고    scopus 로고
    • Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial
    • Memantine Study Group 14734594 1:CAS:528:DC%2BD2cXmtlantA%3D%3D
    • Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, Memantine Study Group (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial. JAMA 291:317-324
    • (2004) JAMA , vol.291 , pp. 317-324
    • Tariot, P.N.1    Farlow, M.R.2    Grossberg, G.T.3    Graham, S.M.4    McDonald, S.5    Gergel, I.6
  • 91
    • 0042433479 scopus 로고    scopus 로고
    • The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development
    • 12805474 1:CAS:528:DC%2BD3sXmvVehsb8%3D
    • Terry AV Jr, Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821-827
    • (2003) J Pharmacol Exp Ther , vol.306 , pp. 821-827
    • Terry, Jr.A.V.1    Buccafusco, J.J.2
  • 92
    • 77952351441 scopus 로고    scopus 로고
    • G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease
    • Thathiah A, De Strooper B (2009) G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease. Sci Signal 2:1-7
    • (2009) Sci Signal , vol.2 , pp. 1-7
    • Thathiah, A.1    De Strooper, B.2
  • 93
    • 0035958739 scopus 로고    scopus 로고
    • Cholinergic nerve terminals establish classical synapses in the rat cerebral cortex: Synaptic pattern and age-related atrophy
    • 11672595 1:CAS:528:DC%2BD3MXlslersbk%3D
    • Turrini P, Casu MA, Wong TP, De Koninck Y, Ribeiro-da-Silva A, Cuello AC (2001) Cholinergic nerve terminals establish classical synapses in the rat cerebral cortex: synaptic pattern and age-related atrophy. Neuroscience 105:277-285
    • (2001) Neuroscience , vol.105 , pp. 277-285
    • Turrini, P.1    Casu, M.A.2    Wong, T.P.3    De Koninck, Y.4    Ribeiro-Da-Silva, A.5    Cuello, A.C.6
  • 94
    • 33646459451 scopus 로고    scopus 로고
    • A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil
    • Memantine MEM-MD-02 Study Group 16670247
    • van Dyck CH, Schmitt FA, Olin JT, Memantine MEM-MD-02 Study Group (2006) A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. Am J Geriatr Psychiatry 14:428-437
    • (2006) Am J Geriatr Psychiatry , vol.14 , pp. 428-437
    • Van Dyck, C.H.1    Schmitt, F.A.2    Olin, J.T.3
  • 95
    • 46249099143 scopus 로고    scopus 로고
    • Memantine therapy for Alzheimer disease in real-world practice: An observational study in a large representative sample of French patients
    • 18525283 1:CAS:528:DC%2BD1cXms1ymtrk%3D
    • Vidal JS, Lacombe JM, Dartigues JF, Pasquier F, Robert P, Tzourio C, Alperovitch A (2008) Memantine therapy for Alzheimer disease in real-world practice: an observational study in a large representative sample of French patients. Alzheimer Dis Assoc Disord 22:125-130
    • (2008) Alzheimer Dis Assoc Disord , vol.22 , pp. 125-130
    • Vidal, J.S.1    Lacombe, J.M.2    Dartigues, J.F.3    Pasquier, F.4    Robert, P.5    Tzourio, C.6    Alperovitch, A.7
  • 97
    • 0032741056 scopus 로고    scopus 로고
    • Selectivity of cholinesterase inhibition: Clinical implications for the treatment of Alzheimer's disease
    • 1:CAS:528:DyaK1MXnsVehtLk%3D
    • Weinstock M (1999) Selectivity of cholinesterase inhibition: clinical implications for the treatment of Alzheimer's disease. CNS Drugs 12:307-323
    • (1999) CNS Drugs , vol.12 , pp. 307-323
    • Weinstock, M.1
  • 98
    • 0028048433 scopus 로고
    • Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat
    • 7812791 1:CAS:528:DyaK2cXlslWisbw%3D
    • Wenk GL, Danysz W, Mobley SL (1994) Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat. Brain Res 655:7-11
    • (1994) Brain Res , vol.655 , pp. 7-11
    • Wenk, G.L.1    Danysz, W.2    Mobley, S.L.3
  • 99
    • 0028980903 scopus 로고
    • MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis
    • 8666045 1:CAS:528:DyaK2MXosVOisLc%3D
    • Wenk GL, Danysz W, Mobley SL (1995) MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis. Eur J Pharmacol 293:267-270
    • (1995) Eur J Pharmacol , vol.293 , pp. 267-270
    • Wenk, G.L.1    Danysz, W.2    Mobley, S.L.3
  • 100
    • 0034635589 scopus 로고    scopus 로고
    • No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use
    • 10737358 1:CAS:528:DC%2BD3cXhsVKisL0%3D
    • Wenk GL, Quack G, Moebius HJ, Danysz W (2000) No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use. Life Sci 66:1079-1083
    • (2000) Life Sci , vol.66 , pp. 1079-1083
    • Wenk, G.L.1    Quack, G.2    Moebius, H.J.3    Danysz, W.4
  • 101
    • 33748296153 scopus 로고    scopus 로고
    • Potential role of N-methyl-d-aspartate receptors as executors of neurodegeneration resulting from diverse insults: Focus on memantine
    • 16940762 1:CAS:528:DC%2BD28XoslOnt74%3D
    • Wenk GL, Parsons CG, Danysz W (2006) Potential role of N-methyl-d-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine. Behav Pharmacol 17:411-424
    • (2006) Behav Pharmacol , vol.17 , pp. 411-424
    • Wenk, G.L.1    Parsons, C.G.2    Danysz, W.3
  • 102
    • 34249037440 scopus 로고    scopus 로고
    • Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil
    • 17519086 1:CAS:528:DC%2BD2sXnt1Whu7w%3D
    • Weycker D, Taneja C, Edelsberg J, Erder MH, Schmitt FA, Setyawan J, Oster G (2007) Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. Curr Med Res Opin 23:1187-1197
    • (2007) Curr Med Res Opin , vol.23 , pp. 1187-1197
    • Weycker, D.1    Taneja, C.2    Edelsberg, J.3    Erder, M.H.4    Schmitt, F.A.5    Setyawan, J.6    Oster, G.7
  • 103
    • 42249111378 scopus 로고    scopus 로고
    • Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: A pooled analysis of 3 studies
    • 18294023 1:CAS:528:DC%2BD1cXltVKhur0%3D
    • Wilcock GK, Ballard CG, Cooper JA, Loft H (2008) Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. J Clin Psychiatry 69:341-348
    • (2008) J Clin Psychiatry , vol.69 , pp. 341-348
    • Wilcock, G.K.1    Ballard, C.G.2    Cooper, J.A.3    Loft, H.4
  • 104
    • 34447633346 scopus 로고    scopus 로고
    • Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease
    • 17622761 1:CAS:528:DC%2BD2sXotVajs7c%3D
    • Wilkinson D, Andersen HF (2007) Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease. Dement Geriatr Cogn Disord 24:138-145
    • (2007) Dement Geriatr Cogn Disord , vol.24 , pp. 138-145
    • Wilkinson, D.1    Andersen, H.F.2
  • 105
    • 2942514710 scopus 로고    scopus 로고
    • Cholinesterase inhibitors used in the treatment of Alzheimer's disease: The relationship between pharmacological effects and clinical efficacy
    • 15132713 1:CAS:528:DC%2BD2cXlsVCmurg%3D
    • Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J (2004) Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 21:453-478
    • (2004) Drugs Aging , vol.21 , pp. 453-478
    • Wilkinson, D.G.1    Francis, P.T.2    Schwam, E.3    Payne-Parrish, J.4
  • 106
    • 0033856448 scopus 로고    scopus 로고
    • The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclo-oxygenase-2 inhibition
    • 11026726 1:CAS:528:DC%2BD3cXnsVers7o%3D
    • Willard LB, Hauss-Wegrzyniak B, Danysz W, Wenk GL (2000) The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclo-oxygenase-2 inhibition. Exp Brain Res 134:58-65
    • (2000) Exp Brain Res , vol.134 , pp. 58-65
    • Willard, L.B.1    Hauss-Wegrzyniak, B.2    Danysz, W.3    Wenk, G.L.4
  • 107
    • 34250797930 scopus 로고    scopus 로고
    • Memantine in moderate to severe Alzheimer's disease: A meta-analysis of randomised clinical trials
    • 17496417 1:CAS:528:DC%2BD2sXmvFSnu7c%3D
    • Winblad B, Jones RW, Wirth Y, Stöffler A, Möbius HJ (2007) Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials. Dement Geriatr Cogn Disord 24:20-27
    • (2007) Dement Geriatr Cogn Disord , vol.24 , pp. 20-27
    • Winblad, B.1    Jones, R.W.2    Wirth, Y.3    Stöffler, A.4    Möbius, H.J.5
  • 108
    • 0029417021 scopus 로고
    • β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus
    • 8747164 1:CAS:528:DyaK28XhtVOjurk%3D
    • Wu J, Anwyl R, Rowan MJ (1995) β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. NeuroReport 6:2409-2413
    • (1995) NeuroReport , vol.6 , pp. 2409-2413
    • Wu, J.1    Anwyl, R.2    Rowan, M.J.3
  • 109
    • 3142666106 scopus 로고    scopus 로고
    • Group i metabotropic glutamate receptor activation produces a direct excitation of identified septohippocampal cholinergic neurons
    • 15044519 1:CAS:528:DC%2BD2cXmslCnt7s%3D
    • Wu M, Hajszan T, Xu C, Leranth C, Alreja M (2004) Group I metabotropic glutamate receptor activation produces a direct excitation of identified septohippocampal cholinergic neurons. J Neurophysiol 92:1216-1225
    • (2004) J Neurophysiol , vol.92 , pp. 1216-1225
    • Wu, M.1    Hajszan, T.2    Xu, C.3    Leranth, C.4    Alreja, M.5
  • 111
    • 0030841116 scopus 로고    scopus 로고
    • Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP
    • 9257940 1:CAS:528:DyaK2sXkvFCltrs%3D
    • Zajaczkowski W, Frankiewicz T, Parsons CG, Danysz W (1997) Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP. Neuropharmacology 36:961-971
    • (1997) Neuropharmacology , vol.36 , pp. 961-971
    • Zajaczkowski, W.1    Frankiewicz, T.2    Parsons, C.G.3    Danysz, W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.